Diabetic foot ulcer (DFU) is a very serious side effect among the diabetic patients with substantial clinical and economic consequences. The aim of this study was to investigate the efficacy of cows' milk topical ointment, as an available and cost-effective natural product, on accelerating the healing of DFU. In this randomized controlled clinical trial, patients with grade 1 or 2 DFU were randomly divided into two groups of intervention (n = 50) and control (n = 49). For patients of intervention group, cows' milk 20% topical ointment was applied on the ulcer once daily for two weeks, while a type of novel dressing was used for control group with the same frequency and duration. Both groups received usual standard wound care measures. The percentage of change in the ulcer size and the number of cases with complete wound healing (>90% reduction in the ulcer size) were recorded in the both groups. The ulcer size significantly reduced in both groups on the seventh and 14 days of intervention; however, the percentage of reduction was significantly higher in the intervention (milk) group compared to control at both time points (44.64 ± 15.98 vs. 24.95 ± 12.78,  < .001; 67.67 ± 22.15 vs. 42.87 ± 19.74,  < .001). Furthermore, although more patients in the intervention group (n = 4, 8%) showed complete healing of the ulcer compared to control (n = 0), the difference was not statistically significant ( = .117). Cow's milk 20% topical ointment improves and accelerates the healing of diabetic foot ulcers. However, more clinical studies are required to confirm these effects.

Download full-text PDF

Source
http://dx.doi.org/10.1177/15347346221084788DOI Listing

Publication Analysis

Top Keywords

ulcer size
12
diabetic foot
8
randomized controlled
8
clinical trial
8
cows' milk
8
topical ointment
8
ulcer
5
topical cow's
4
milk
4
cow's milk
4

Similar Publications

Marginal ulcers are a common complication following Roux-en-Y bypass surgeries with an approximate incidence of 4.6%. The pathophysiology is complex and risk factors include smoking, nonsteroidal anti-inflammatory drugs (NSAIDs) use, Helicobacter pylori infection, and a larger pouch size.

View Article and Find Full Text PDF

Programmable Food-Derived Peptide Coassembly Strategies for Boosting Targeted Colitis Therapy by Enhancing Oral Bioavailability and Restoring Gut Microenvironment Homeostasis.

ACS Nano

January 2025

Jilin Provincial Key Laboratory of Nutrition and Functional Food, College of Food Science and Engineering, Jilin University, Changchun 130062, China.

Article Synopsis
  • Recent advancements in orally-targeted nanostrategies using multiple nutraceuticals show promise for ulcerative colitis therapy, improving patient compliance and effectiveness despite challenges like poor solubility and gastrointestinal retention.
  • The study introduces nanoparticles crafted from quaternary ammonium chitosan and succinic acid-modified γ-cyclodextrin, with egg white-derived peptides enhancing the delivery and bioavailability of hydrophobic curcumin.
  • Findings indicate that these nanoparticles significantly increase cellular absorption and oral bioavailability, support colonic microenvironment interactions, and promote intestinal health through improved amino acid metabolism.
View Article and Find Full Text PDF

Pyoderma Gangrenosum: A Nightmare for Breast Surgery-Two Case Reports.

Eur J Breast Health

January 2025

Department of General Surgery, Gülhane Training and Research Hospital, University of Health Sciences Turkey, Ankara, Turkey.

Article Synopsis
  • Pyoderma gangrenosum (PG) is a rare skin condition that causes painful ulcers and is often incorrectly diagnosed as an infection.
  • The report discusses two cases of PG following breast surgeries, where both patients initially received ineffective treatment through debridements and antibiotics.
  • Effective treatment was achieved using oral doxycycline and topical tacrolimus, highlighting the importance of early diagnosis and proper management to prevent patient suffering and disfigurement.
View Article and Find Full Text PDF
Article Synopsis
  • Non-healing diabetic foot ulcers (DFUs) pose a risk for amputations, and hyperbaric oxygen therapy (HBOT) is explored as a potential treatment to enhance healing and lower amputation rates, although its effectiveness remains debated.
  • A study was conducted with 60 adult patients with DFUs, randomly assigning them to two groups: one receiving HBOT alongside standard wound care (SWC) and the other receiving SWC alone, evaluating various outcomes over four weeks.
  • Results indicated that patients receiving HBOT showed significantly greater improvements in pain, wound size, and healthy tissue formation, as well as a lower incidence of minor amputations compared to those with SWC alone.
View Article and Find Full Text PDF

Establishment of an oral burn model in streptozotocin-induced diabetic rats.

Maxillofac Plast Reconstr Surg

December 2024

Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, 7, Jukheon-Gil, Gangneung, Gangwondo, 28644, Republic of Korea.

Background: Oral ulcers are painful mucosal lesions prone to infection and inflammation. To evaluate the effectiveness of treatments, a suitable experimental animal model with an appropriate healing period is required. The aim of this study was to develop an animal model for oral ulcer research by comparing oral burn wounds of different sizes and locations in diabetic rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!